116 related articles for article (PubMed ID: 27191386)
1. Targeting the Motion of Shikimate Kinase: Development of Competitive Inhibitors that Stabilize an Inactive Open Conformation of the Enzyme.
Prado V; Lence E; Maneiro M; Vázquez-Ucha JC; Beceiro A; Thompson P; Hawkins AR; González-Bello C
J Med Chem; 2016 Jun; 59(11):5471-87. PubMed ID: 27191386
[TBL] [Abstract][Full Text] [Related]
2. Freezing the Dynamic Gap for Selectivity: Motion-Based Design of Inhibitors of the Shikimate Kinase Enzyme.
Prado V; Lence E; Thompson P; Hawkins AR; González-Bello C
Chemistry; 2016 Dec; 22(50):17988-18000. PubMed ID: 27699905
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.
Blanco B; Prado V; Lence E; Otero JM; Garcia-Doval C; van Raaij MJ; Llamas-Saiz AL; Lamb H; Hawkins AR; González-Bello C
J Am Chem Soc; 2013 Aug; 135(33):12366-76. PubMed ID: 23889343
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Helicobacter pylori shikimate kinase inhibitors: bioassay and molecular modeling.
Han C; Zhang J; Chen L; Chen K; Shen X; Jiang H
Bioorg Med Chem; 2007 Jan; 15(2):656-62. PubMed ID: 17098431
[TBL] [Abstract][Full Text] [Related]
5. Structures of Helicobacter pylori shikimate kinase reveal a selective inhibitor-induced-fit mechanism.
Cheng WC; Chen YF; Wang HJ; Hsu KC; Lin SC; Chen TJ; Yang JM; Wang WC
PLoS One; 2012; 7(3):e33481. PubMed ID: 22438938
[TBL] [Abstract][Full Text] [Related]
6. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
[TBL] [Abstract][Full Text] [Related]
7. Study of the Phosphoryl-Transfer Mechanism of Shikimate Kinase by NMR Spectroscopy.
Prado V; Lence E; Vallejo JA; Beceiro A; Thompson P; Hawkins AR; González-Bello C
Chemistry; 2016 Feb; 22(8):2758-68. PubMed ID: 26797764
[TBL] [Abstract][Full Text] [Related]
8. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
[TBL] [Abstract][Full Text] [Related]
9. Integration of virtual screening and susceptibility test to discover active-site subpocket-specific biogenic inhibitors of Helicobacter pylori shikimate dehydrogenase.
Wang K; Zhu M; Tang Y; Liu J; Yan F; Yu Z; Zhu J
Int Microbiol; 2019 Mar; 22(1):69-80. PubMed ID: 30810934
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel scaffold using ligand and structure based approach targeting shikimate kinase.
Rahul Reddy MB; Krishnasamy SK; Kathiravan MK
Bioorg Chem; 2020 Sep; 102():104083. PubMed ID: 32745735
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies.
Gonzalez-Bello C
Curr Top Med Chem; 2016; 16(9):960-77. PubMed ID: 26303426
[TBL] [Abstract][Full Text] [Related]
12. Competitive inhibitors of Helicobacter pylori type II dehydroquinase: synthesis, biological evaluation, and NMR studies.
Sánchez-Sixto C; Prazeres VF; Castedo L; Suh SW; Lamb H; Hawkins AR; Cañada FJ; Jiménez-Barbero J; González-Bello C
ChemMedChem; 2008 May; 3(5):756-70. PubMed ID: 18200648
[TBL] [Abstract][Full Text] [Related]
13. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis.
Gu Y; Reshetnikova L; Li Y; Wu Y; Yan H; Singh S; Ji X
J Mol Biol; 2002 Jun; 319(3):779-89. PubMed ID: 12054870
[TBL] [Abstract][Full Text] [Related]
15. Shikimate kinase: a potential target for development of novel antitubercular agents.
Pereira JH; Vasconcelos IB; Oliveira JS; Caceres RA; de Azevedo WF; Basso LA; Santos DS
Curr Drug Targets; 2007 Mar; 8(3):459-68. PubMed ID: 17348838
[TBL] [Abstract][Full Text] [Related]
16. Crystallographic studies of shikimate binding and induced conformational changes in Mycobacterium tuberculosis shikimate kinase.
Dhaliwal B; Nichols CE; Ren J; Lockyer M; Charles I; Hawkins AR; Stammers DK
FEBS Lett; 2004 Sep; 574(1-3):49-54. PubMed ID: 15358538
[TBL] [Abstract][Full Text] [Related]
17. Effects of the magnesium and chloride ions and shikimate on the structure of shikimate kinase from Mycobacterium tuberculosis.
Dias MV; Faím LM; Vasconcelos IB; de Oliveira JS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jan; 63(Pt 1):1-6. PubMed ID: 17183161
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues.
Prazeres VF; Tizón L; Otero JM; Guardado-Calvo P; Llamas-Saiz AL; van Raaij MJ; Castedo L; Lamb H; Hawkins AR; González-Bello C
J Med Chem; 2010 Jan; 53(1):191-200. PubMed ID: 19911771
[TBL] [Abstract][Full Text] [Related]
19. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
[TBL] [Abstract][Full Text] [Related]
20. Probing binding requirements of NAD kinase with modified substrate (NAD) analogues.
Bonnac L; Chen L; Pathak R; Gao G; Ming Q; Bennett E; Felczak K; Kullberg M; Patterson SE; Mazzola F; Magni G; Pankiewicz KW
Bioorg Med Chem Lett; 2007 Mar; 17(6):1512-5. PubMed ID: 17258457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
